Showing results (1801-1810 of 1,943) with videos related to

Sort By:
Pageof 195
The Journal of Antimicrobial Chemotherapy|May 16, 2020
Letermovir breakthroughs during the French Named Patient Programme: interest of monitoring blood concentration in clinical practiceS Alain, L Feghoul, S Girault, et al.
Leukemia|October 22, 2011
Characterization of intratumoral follicular helper T cells in follicular lymphoma: role in the survival of malignant B cellsP Amé-Thomas, J Le Priol, H Yssel, et al.
Contact Dermatitis|April 10, 2014
Patch testing with methylchloroisothiazolinone/methylisothiazolinone 200 ppm aq. detects significantly more contact allergy than 100 ppm. A multicentre study within the European Environmental and Contact Dermatitis Research GroupMagnus Bruze, Marléne Isaksson, Birgitta Gruvberger, et al.
Developments in Biological Standardization|January 1, 1992
Protodyne: an immunostimulatory protein component, prepared from gram-positive Bacillus subtilisV Houba, F M Berger, C A Dinarello, et al.
La Revue De Medecine Interne|May 8, 2024
[Short antibiotic therapy in hospitalized pneumonia: A cohort study]L Bouyakoub, A Dinh, D Blez, et al.
Revue Des Maladies Respiratoires|May 1, 2007
[Postembolic pulmonary hypertension]X Jais, P Dartevelle, F Parent, et al.
Environmental Toxicology and Pharmacology|July 26, 2011
Antigenotoxic and antioxidant activities of Pituranthos chloranthus essential oilsA Neffati, I Bouhlel, M Ben Sghaier, et al.
Breast Cancer Research and Treatment|August 10, 2000
Somatostatin receptor in breast cancer and axillary nodes: study with scintigraphy, histopathology and receptor autoradiographyJ L Albérini, B Meunier, B Denzler, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 4, 2018
Screening for active tuberculosis before isoniazid preventive therapy among HIV-infected West African adultsR Moh, A Badjé, J-B N'takpé, et al.
The Journal of Biological Chemistry|February 13, 1999
The -700/-310 fragment of the apolipoprotein A-IV gene combined with the -890/-500 apolipoprotein C-III enhancer is sufficient to direct a pattern of gene expression similar to that for the endogenous apolipoprotein A-IV geneJ Le Beyec, V Chauffeton, H Y Kan, et al.
Pageof 195